{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:21:35Z","timestamp":1791336095758,"version":"4.3.1"},"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T00:00:00Z","timestamp":1291334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0014227","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T20:20:19Z","timestamp":1291407619000},"page":"e14227","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II"],"prefix":"10.1371","volume":"5","author":[{"given":"Walid","family":"Mokni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Keravis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Etienne-Selloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modou O.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie B.","family":"Schini-Kerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lugnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,12,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"54D","DOI":"10.1016\/S0002-9149(99)80493-7","article-title":"Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis.","volume":"76","author":"A Bayes-Genis","year":"1995","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"II10","DOI":"10.1002\/clc.4960161404","article-title":"Structural basis for pathologic left ventricular hypertrophy.","volume":"16","author":"KT Weber","year":"1993","journal-title":"Clin Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/hh0901.089882","article-title":"Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function.","volume":"88","author":"GG Serneri","year":"2001","journal-title":"Circ Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.","volume":"292","author":"PK Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-6997(24)01471-6","article-title":"Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.","volume":"52","author":"RM Touyz","year":"2000","journal-title":"Pharmacol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00005344-199003000-00015","article-title":"Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.","volume":"15","author":"B Muller","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection.","volume":"69","author":"T Nishikimi","year":"2006","journal-title":"Cardiovasc Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/0006-2952(79)90403-9","article-title":"Age related changes in cardiac and aortic phosphodiesterase activities in normotensive and hypertensive rats.","volume":"28","author":"C Lugnier","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.","volume":"75","author":"JA Beavo","year":"1995","journal-title":"Physiol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.","volume":"109","author":"C Lugnier","year":"2006","journal-title":"Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(00)65001-8","article-title":"Cyclic nucleotide phosphodiesterases: relating structure and function.","volume":"65","author":"SH Francis","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1271\/bbb.67.973","article-title":"cGMP-phosphodiesterase activity is up-regulated in response to pressure overload of rat ventricles.","volume":"67","author":"N Yanaka","year":"2003","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s003800200032","article-title":"Enhanced activities and gene expression of phosphodiesterase types 3 and 4 in pressure-induced congestive heart failure.","volume":"16","author":"K Takahashi","year":"2002","journal-title":"Heart Vessels"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2005.07.030","article-title":"Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.","volume":"123","author":"SE Lehnart","year":"2005","journal-title":"Cell"},{"key":"ref15","article-title":"Ventricular Phosphodiesterase-5 Expression Is Increased in Patients With Advanced Heart Failure and Contributes to Adverse Ventricular Remodeling After Myocardial Infarction in Mice.","author":"P Pokreisz","year":"2009","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.0000165128.39715.87","article-title":"Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.","volume":"111","author":"B Ding","year":"2005","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1161\/01.CIR.96.9.3116","article-title":"Development of decompensated dilated cardiomyopathy is associated with decreased gene expression and activity of the milrinone-sensitive cAMP phosphodiesterase PDE3A.","volume":"96","author":"CJ Smith","year":"1997","journal-title":"Circulation"},{"key":"ref18","first-page":"833","article-title":"A phosphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension.","volume":"94","author":"D Badenhorst","year":"2004","journal-title":"S Afr Med J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/sj.bjp.0705567","article-title":"Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.","volume":"140","author":"KC Wollert","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/hh0102.103222","article-title":"cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium.","volume":"90","author":"JW Wegener","year":"2002","journal-title":"Circ Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.","volume":"116","author":"J Nagendran","year":"2007","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.","volume":"11","author":"E Takimoto","year":"2005","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.91438.2007","article-title":"Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.","volume":"294","author":"FN Salloum","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000121408","article-title":"Angiotensin II Induces the Vascular Expression of VEGF and MMP-2 in vivo: Preventive Effect of Red Wine Polyphenols.","volume":"45","author":"A Walter","year":"2008","journal-title":"J Vasc Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent.","volume":"193","author":"OH Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0021-9258(19)68051-8","article-title":"The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.","volume":"233","author":"JM Kissane","year":"1958","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/bjp.2008.56","article-title":"Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.","volume":"154","author":"M Campos-Toimil","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/BJ20050030","article-title":"Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.","volume":"388","author":"W Richter","year":"2005","journal-title":"Biochem J"},{"key":"ref29","first-page":"63","article-title":"Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts.","volume":"307","author":"T Keravis","year":"2005","journal-title":"Methods Mol Biol"},{"key":"ref30","first-page":"141","article-title":"Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.","volume":"14","author":"C Lugnier","year":"1993","journal-title":"Eur Heart J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0898-6568(95)00042-N","article-title":"Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine.","volume":"7","author":"T Podzuweit","year":"1995","journal-title":"Cell Signal"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/0006-2952(95)02031-4","article-title":"Characterization of a novel potent and specific inhibitor of type V phosphodiesterase.","volume":"50","author":"H Coste","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"ref33","first-page":"81","article-title":"EHNA as an Inhibitor of PDE2: A Pharmacological and Biochemical Study in Cardiac Myocytes.","author":"PF Mery","year":"1996"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2105-7-85","article-title":"Statistical analysis of real-time PCR data.","volume":"7","author":"JS Yuan","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.RES.0000152262.22968.72","article-title":"cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.","volume":"96","author":"E Takimoto","year":"2005","journal-title":"Circ Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","article-title":"AMPK alterations in cardiac physiology and pathology: enemy or ally?","volume":"574","author":"JR Dyck","year":"2006","journal-title":"J Physiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1159\/000109148","article-title":"Involvement of NADPH oxidases in cardiac remodelling and heart failure.","volume":"27","author":"A Sirker","year":"2007","journal-title":"Am J Nephrol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1582-4934.2004.tb00270.x","article-title":"Redox regulation of angiotensin II signaling in the heart.","volume":"8","author":"DK Das","year":"2004","journal-title":"J Cell Mol Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology.","volume":"87","author":"K Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.yjmcc.2007.03.140","article-title":"Identification of PDE1 et PDE5 in adult rat left ventricular cardiomyocytes.","volume":"42","author":"T Keravis","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.RES.0000246118.98832.04","article-title":"Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.","volume":"99","author":"R Fischmeister","year":"2006","journal-title":"Circ Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"9140","DOI":"10.1074\/jbc.M805366200","article-title":"The Cardiac IKs Potassium Channel Macromolecular Complex Includes the Phosphodiesterase PDE4D3.","volume":"284","author":"C Terrenoire","year":"2009","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cbpb.2005.04.012","article-title":"Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.","volume":"142","author":"R Fischmeister","year":"2005","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.RES.0000200178.34179.93","article-title":"Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO\/cGMP-dependent pathway.","volume":"98","author":"M Mongillo","year":"2006","journal-title":"Circ Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.109.197947","article-title":"Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals.","volume":"105","author":"A Abi-Gerges","year":"2009","journal-title":"Circ Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"28298","DOI":"10.1074\/jbc.M108353200","article-title":"TAPAS-1, a novel microdomain within the unique N-terminal region of the PDE4A1 cAMP-specific phosphodiesterase that allows rapid, Ca2+-triggered membrane association with selectivity for interaction with phosphatidic acid.","volume":"277","author":"GS Baillie","year":"2002","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jnnp.2006.092106","article-title":"Association between phosphodiesterase 4D gene and ischaemic stroke.","volume":"77","author":"JM Staton","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1245","article-title":"The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.","volume":"35","author":"S Gretarsdottir","year":"2003","journal-title":"Nat Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1074\/jbc.M006546200","article-title":"Myomegalin is a novel protein of the golgi\/centrosome that interacts with a cyclic nucleotide phosphodiesterase.","volume":"276","author":"I Verde","year":"2001","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/emboj\/20.8.1921","article-title":"mAKAP assembles a protein kinase A\/PDE4 phosphodiesterase cAMP signaling module.","volume":"20","author":"KL Dodge","year":"2001","journal-title":"EMBO J"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0304-4165(99)00145-2","article-title":"Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei.","volume":"1472","author":"C Lugnier","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"49230","DOI":"10.1074\/jbc.M303772200","article-title":"The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestins.","volume":"278","author":"GB Bolger","year":"2003","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1016\/S0021-9258(18)81703-3","article-title":"Regulation of Ca2+\/calmodulin-dependent cyclic nucleotide phosphodiesterase by the autophosphorylated form of Ca2+\/calmodulin-dependent protein kinase II.","volume":"264","author":"Y Hashimoto","year":"1989","journal-title":"J Biol Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.109.198515","article-title":"Role of Ca2+\/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.","volume":"105","author":"CL Miller","year":"2009","journal-title":"Circ Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/hc4401.098432","article-title":"Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.","volume":"104","author":"D Kim","year":"2001","journal-title":"Circulation"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1006\/jmcc.1997.0544","article-title":"Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.","volume":"29","author":"MM Kostic","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"32749","DOI":"10.1074\/jbc.M703173200","article-title":"Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes.","volume":"282","author":"F Vandeput","year":"2007","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/hh0202.104108","article-title":"Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation.","volume":"90","author":"SD Rybalkin","year":"2002","journal-title":"Circ Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"L294","DOI":"10.1152\/ajplung.00190.2006","article-title":"Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1.","volume":"292","author":"F Murray","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yjmcc.2004.10.013","article-title":"Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.","volume":"38","author":"D Kim","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.cellsig.2008.08.012","article-title":"Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes.","volume":"20","author":"M Zhang","year":"2008","journal-title":"Cell Signal"},{"key":"ref63","article-title":"Six months of Sildenafil therapy improves heart rate recovery in patients with heart failure.","author":"M Guazzi","year":"2008","journal-title":"Int J Cardiol"},{"key":"ref64","first-page":"408","article-title":"Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.","volume":"119","author":"E Takimoto","year":"2009","journal-title":"J Clin Invest"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11897-006-0011-0","article-title":"The emerging role for type 5 phosphodiesterase inhibition in heart failure.","volume":"3","author":"GD Lewis","year":"2006","journal-title":"Curr Heart Fail Rep"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1523\/JNEUROSCI.23-16-06452.2003","article-title":"Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.","volume":"23","author":"M Shimizu-Albergine","year":"2003","journal-title":"J Neurosci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-3-540-68964-5_16","article-title":"Cyclic GMP-hydrolyzing phosphodiesterases.","author":"SH Francis","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1471-4159.2002.00903.x","article-title":"Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation.","volume":"81","author":"KL Ang","year":"2002","journal-title":"J Neurochem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.bbrc.2006.01.035","article-title":"Subcellular localization and regulation of type-1C and type-5 phosphodiesterases.","volume":"341","author":"S Dolci","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000087541.15600.2B","article-title":"Cyclic GMP phosphodiesterases and regulation of smooth muscle function.","volume":"93","author":"SD Rybalkin","year":"2003","journal-title":"Circ Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.RES.0000215576.27615.fd","article-title":"Role of nuclear Ca2+\/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.","volume":"98","author":"DJ Nagel","year":"2006","journal-title":"Circ Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardfail.2008.09.005","article-title":"Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.","volume":"15","author":"J Stehlik","year":"2009","journal-title":"J Card Fail"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"L723","DOI":"10.1152\/ajplung.00485.2004","article-title":"Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension.","volume":"290","author":"OV Evgenov","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1465-9921-6-76","article-title":"Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.","volume":"6","author":"RT Schermuly","year":"2005","journal-title":"Respir Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1046\/j.1432-1327.1999.00123.x","article-title":"Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction.","volume":"259","author":"V Geoffroy","year":"1999","journal-title":"Eur J Biochem"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/CIRCULATIONAHA.105.599241","article-title":"Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.","volume":"113","author":"LR Castro","year":"2006","journal-title":"Circulation"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI118092","article-title":"Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression.","volume":"96","author":"H Fujisaki","year":"1995","journal-title":"J Clin Invest"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jacc.2006.08.066","article-title":"Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.","volume":"49","author":"PR Forfia","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2337\/db08-1293","article-title":"Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization.","volume":"58","author":"M Kelly","year":"2009","journal-title":"Diabetes"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pharmthera.2008.05.008","article-title":"Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease.","volume":"119","author":"DS Hutchinson","year":"2008","journal-title":"Pharmacol Ther"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.RES.0000258446.23525.37","article-title":"AMP-activated protein kinase in the heart: role during health and disease.","volume":"100","author":"M Arad","year":"2007","journal-title":"Circ Res"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbrc.2008.01.099","article-title":"Inhibitory crosstalk between ERK and AMPK in the growth and proliferation of cardiac fibroblasts.","volume":"368","author":"J Du","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref83","article-title":"AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia\/Reperfusion Injury but Has Minimal Effect on the Antioxidant\/Antinitrative Protection of Adiponectin.","author":"Y Wang","year":"2009","journal-title":"Circulation"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.108.114702","article-title":"AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.","volume":"52","author":"P Zhang","year":"2008","journal-title":"Hypertension"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure.","volume":"104","author":"S Gundewar","year":"2009","journal-title":"Circ Res"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.1074\/jbc.M802869200","article-title":"Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.","volume":"283","author":"AY Chan","year":"2008","journal-title":"J Biol Chem"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"32562","DOI":"10.1074\/jbc.M801904200","article-title":"Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.","volume":"283","author":"BJ Stuck","year":"2008","journal-title":"J Biol Chem"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jcb.21197","article-title":"Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.","volume":"100","author":"HL Li","year":"2007","journal-title":"J Cell Biochem"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1161\/CIRCULATIONAHA.108.828426","article-title":"Reactive oxygen species-induced stimulation of 5\u2032AMP-activated protein kinase mediates sevoflurane-induced cardioprotection.","volume":"120","author":"RR Lamberts","year":"2009","journal-title":"Circulation"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yjmcc.2009.04.004","article-title":"NADPH oxidase signaling and cardiac myocyte function.","volume":"47","author":"A Akki","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.2741\/3443","article-title":"Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure.","volume":"14","author":"N Anilkumar","year":"2009","journal-title":"Front Biosci"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00029.2005","article-title":"Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.","volume":"26","author":"SD Hingtgen","year":"2006","journal-title":"Physiol Genomics"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cardiores.2006.07.006","article-title":"Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes.","volume":"72","author":"A Laskowski","year":"2006","journal-title":"Cardiovasc Res"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.109.212530","article-title":"AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.","volume":"106","author":"S Wang","year":"2010","journal-title":"Circ Res"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.108.784289","article-title":"Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction.","volume":"118","author":"E Schulz","year":"2008","journal-title":"Circulation"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCRESAHA.109.194274","article-title":"When metabolism rules perfusion: AMPK-mediated endothelial nitric oxide synthase activation.","volume":"104","author":"E Schulz","year":"2009","journal-title":"Circ Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0014227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:13:43Z","timestamp":1740744823000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0014227"}},"subtitle":[],"editor":[{"given":"Karl-Wilhelm","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,3]]},"references-count":96,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0014227","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,3]]}}}